Daewon Pharmaceutical Reports Phase 3 Success for Padoprazan
Daewon Pharmaceutical said its next-generation stomach drug, padoprazan, succeeded in a Phase 3 clinical trial.
Daewon Pharmaceutical said its next-generation stomach drug, padoprazan, succeeded in a Phase 3 clinical trial.